Fact-checked by Grok 2 weeks ago

Megasphaera

Megasphaera is a genus of Gram-negative, obligately anaerobic, nonmotile cocci in the family Megasphaeraceae within the phylum Firmicutes, characterized by fermentative metabolism that produces short-chain fatty acids such as acetate, propionate, and butyrate, as well as hydrogen, carbon dioxide, and hydrogen sulfide. The type species, Megasphaera elsdenii, was originally described as Peptostreptococcus elsdenii in 1959 and reclassified into this genus in 1971 by Rogosa, based on its large spherical cells (typically 1.5–2.5 μm in diameter) and ability to ferment carbohydrates and organic acids like lactate and glucose. Cells often appear in pairs or short chains and possess a porous outer membrane structure that contributes to their Gram-negative staining despite their Firmicutes affiliation. Species of Megasphaera inhabit diverse environments, including the of ruminants such as and sheep, where M. elsdenii plays a key role in utilization to prevent ruminal and supports volatile production for host . In humans, they colonize the , oral cavity, and female genital tract, contributing to microbial diversity in the gut and cervicovaginal . Other habitats include environments, where species like M. cerevisiae, M. paucivorans, and M. sueciensis are implicated in beer spoilage through acid production that alters flavor and stability. Ecologically, these enhance processes in systems, with potential applications in production from organic wastes. Medically, Megasphaera species are associated with in conditions such as , where overgrowth disrupts the vaginal and correlates with infections, , and . In ruminant health, M. elsdenii is explored as a to mitigate in high-grain diets and improve feed efficiency, though its role in milk fat depression remains correlative rather than causative. Industrially, their lactate-fermenting capabilities offer promise for , including propionate and butyrate for feed additives and biofuels. As of November 2025, the comprises 16 validly described species, with ongoing genomic studies revealing metabolic versatility and host interactions.

Taxonomy

Etymology

The genus name Megasphaera derives from the Greek adjective megas (μεγας), meaning "big" or "large," and the Greek noun sphaîra (σφαιρα), meaning "sphere," resulting in the New Latin feminine Megasphaera, which translates to "big sphere." This was explicitly provided by Rogosa in 1971 upon proposing the to accommodate the M. elsdenii, emphasizing the distinctive morphology of the organism's large spherical cells. No variations or disputes in the etymological interpretation of the name have been recorded since its establishment.

Phylogenetic Position

Megasphaera belongs to the phylum (formerly known as Firmicutes), class Negativicutes, order Veillonellales, and family Megasphaeraceae. This placement reflects recent taxonomic revisions based on genomic and phylogenetic analyses, which elevated Megasphaeraceae to family status in 2023 from prior assignments within Veillonellaceae. The genus exhibits a notable in bacterial cell wall structure, staining Gram-negative despite its affiliation with the predominantly monoderm (Gram-positive) phylum . Members of Negativicutes, including Megasphaera, possess a diderm with an outer containing , challenging traditional Gram-positive/negative dichotomies. This diderm trait is a derived characteristic within Firmicutes, supported by phylogenomic studies highlighting the evolutionary acquisition of outer components in this class. Phylogenetic analyses using 16S rRNA gene sequences position Megasphaera closely alongside genera such as and Dialister within the clade. These markers reveal sequence similarities exceeding 90% with these relatives, underscoring shared ancestry in environments. The distinct phylogenetic clade of Megasphaera emerged from molecular studies in the 1970s, initially through the transfer of rumen-derived isolates from Peptostreptococcus to the new genus in 1971. Early 16S rRNA-based investigations confirmed its separation among anaerobic fermentative bacteria in ruminant and human microbiomes.

Classification History

The genus Megasphaera was established in 1971 by Matthew Rogosa, who transferred the species Peptostreptococcus elsdenii (originally described in 1959 from rumen isolates) to the new genus as Megasphaera elsdenii, designating it the type species. This reclassification addressed the anomalous placement of the organism in the Gram-positive genus Peptostreptococcus, as M. elsdenii exhibited Gram-negative characteristics despite phylogenetic links to Firmicutes. Early challenges included its initial misclassification as Gram-positive based on superficial staining, which was resolved through electron microscopy studies in the 1970s revealing a diderm cell wall structure with an outer membrane. The expanded during the and with the addition of new primarily isolated from environments like breweries and the . A notable example is Megasphaera cerevisiae, described in 1986 from spoiled , marking the first species beyond the type and highlighting the genus's role in anaerobic spoilage. Further additions in the , such as M. micronuciformis (proposed in but based on earlier isolates), reflected growing recognition of the genus's diversity in gastrointestinal and industrial settings. The genus was emended in to incorporate characteristics of newly described . Molecular revisions in the 2000s integrated Megasphaera into the newly proposed class Negativicutes in 2010, driven by genomic analyses that confirmed the presence of outer membrane genes (e.g., for lipopolysaccharides) in an otherwise Firmicutes lineage, solidifying its Gram-negative status. This shift emphasized the genus's phylogenetic position among diderm Firmicutes, distinct from typical monoderm Gram-positives. Recent taxonomic updates include the establishment of the family Megasphaeraceae in 2023 by Chuvochina et al., based on genome-derived phylogenomics and metagenomic data from diverse microbiomes, which better delineates Megasphaera from related genera like Veillonella. As of 2025, the genus comprises 16 validly published species, reflecting ongoing discoveries from human and animal microbiomes.

Description

Morphology

Megasphaera species are characterized by their coccoid or spherical morphology, appearing as Gram-negative cocci despite belonging to the Firmicutes phylum, specifically the class Negativicutes. Cells typically measure 0.5–2.0 μm in diameter, with some strains, such as M. elsdenii, exhibiting larger sizes of 2–2.5 μm, which inspired the genus name derived from Greek words meaning "large sphere." This large size is notable among rumen bacteria and distinguishes them from smaller cocci like streptococci (0.7–1.5 μm). Under light microscopy, cells occur singly, in pairs (forming diplococci), or occasionally in short chains, with irregular coccoid shapes observed in certain species. These are non-motile and non-spore-forming, lacking flagella in most strains, which aligns with their strictly lifestyle and adaptation to host-associated environments. Electron microscopy reveals no pili in the majority of examined isolates, further emphasizing their sessile nature. The cell envelope features a thin layer, atypical for Firmicutes, paired with an outer membrane containing lipopolysaccharides (LPS), conferring a diderm structure reminiscent of Gram-negative Proteobacteria. This unusual architecture for the has been confirmed through (TEM) cross-sections, showing a thin peptidoglycan sacculus anchored to the outer membrane via specific lipoproteins.

Physiology

Megasphaera species are obligate anaerobes, intolerant to oxygen exposure, and require strictly anaerobic conditions for growth, typically maintained in atmospheres such as N₂/CO₂/H₂ (80:15:5). They utilize ferredoxin as a key electron carrier in their anaerobic electron transport systems, facilitating energy conservation in the absence of oxygen. These bacteria are mesophilic, with optimal growth occurring at 37°C, though they can tolerate a range of 30–42°C, and a maximum of 45°C. Growth is favored at neutral pH levels between 6.0 and 7.0, within a broader tolerance of 6.0–8.0. Megasphaera species are slow-growing, often requiring 48–72 hours of incubation to form visible colonies on solid media, which appear as small, opaque structures. Nutritionally, Megasphaera are fastidious organisms that demand complex media supplemented with peptides, , and, for certain rumen-associated species like M. elsdenii, fluid to support growth. They reproduce asexually via binary fission and do not form spores, consistent with their non-sporulating nature. As , they exhibit sensitivity to cell wall-targeting antibiotics such as beta-lactams, including penicillin and .

Metabolism

Megasphaera species are obligate that derive energy exclusively through , lacking the ability to use external electron acceptors such as oxygen or . They primarily ferment and , while some strains, including the , utilize simple sugars like glucose and , though many exhibit limited or no utilization of complex carbohydrates such as , , or , as evidenced by the absence of corresponding genes. This metabolic strategy supports their niche in anaerobic environments like the or gut, where they convert these substrates into (SCFAs) without respiratory processes. Amino acid fermentation is a central process in Megasphaera, involving the catabolism of compounds such as glutamate, serine, , , and others derived from protein hydrolysates. For instance, M. elsdenii extensively degrades from acid-hydrolyzed , producing and branched-chain volatile fatty acids (BCVFAs) as byproducts, though free support growth more effectively than peptides. Specific examples include the metabolism of glutamate and serine, which contribute to SCFA formation via and subsequent carbon skeleton utilization, often yielding or propionate alongside . This pathway plays a minor role in energy generation compared to but aids in recycling within microbial communities. Lactate serves as a preferred for many Megasphaera species, undergoing dismutation through the pathway. In M. elsdenii, is oxidized to (generating ATP) while a portion is reduced to propionate via the intermediate acrylyl-CoA, which is further reduced by acrylyl-CoA reductase using reduced as the electron source. The theoretical of this dismutation is approximately 3 mol to 1 mol and 2 mol propionate, plus CO₂. This process also produces hydrogen gas (up to 0.27 mol/mol ) and CO₂, maintaining redox balance without external acceptors; under steady-state conditions, butyrate may accumulate instead of propionate if is absent. Strains like M. hexanoica extend this by incorporating into chain elongation, yielding valerate or caproate. A key fermentative route in Megasphaera involves butyrate production via the butyryl-CoA pathway, where two molecules condense to acetoacetyl-CoA through acetyl-CoA acetyltransferase (ThlA), followed by to butyryl-CoA and conversion to butyrate. This pathway extends in chain-elongating species to produce longer SCFAs, such as caproate (hexanoate) and valerate (pentanoate), through reverse β-oxidation using as an and or butyrate as acceptors. These SCFAs, including butyrate (C4), valerate (C5), and caproate (C6), represent major end products that contribute to the overall energy yield in host-associated microbiomes by providing substrates for absorption and utilization. and CO₂ are common gaseous byproducts across these fermentations, facilitating disposal. Species-specific variations highlight metabolic diversity within the ; for example, M. elsdenii predominantly converts to propionate via the route, while M. hexanoica favors caproate production (up to C8 acids) through efficient reverse β-oxidation of and intermediates. Overall, these capabilities enable Megasphaera to produce SCFAs that serve as energy sources in microbial ecosystems, with sugar varying across .

Ecology

Habitats

Megasphaera species are obligately predominantly inhabiting oxygen-depleted environments within animal and human hosts, as well as select anaerobic ecological niches. The genus was first isolated from the of sheep in 1953, highlighting its early recognition in the gastrointestinal tracts of herbivores such as and sheep, where it contributes to the microbial community in the chamber. In human-associated habitats, Megasphaera is commonly detected in the vaginal tract, oral cavity, and . Within the vaginal microbiota, certain phylotypes like M. type 1 and M. type 2 are uniquely adapted to this environment and are present at low levels in healthy states but become significantly more abundant in dysbiotic conditions such as . In the oral cavity, including and the , Megasphaera species such as M. sp. DISK18 are part of the commensal flora in subgingival plaque, with metagenomic surveys identifying them as a major group even in healthy individuals, though their prevalence increases in periodontal . In the , particularly the colon and , Megasphaera acts as a commensal, with species like M. elsdenii detected across mammalian guts, including humans, at varying abundances depending on diet and health status. Environmentally, Megasphaera occurs in anaerobic sediments, such as those associated with . It is also found in systems undergoing , where it participates in breakdown. Additionally, certain species inhabit environments, contributing to spoilage. However, the genus is rarely found in aerobic waters or soils, reflecting its strict anaerobic requirements that confine it to low-oxygen niches.

Microbiome Roles

In the vaginal microbiome, Megasphaera species, such as M. elsdenii and distinct phylotypes like MP1 and MP2, contribute to dysbiosis by competing with protective Lactobacillus species, which normally dominate healthy communities through acid production and antimicrobial activity. This competition facilitates a shift toward anaerobic overgrowth, reducing Lactobacillus abundance and elevating pH, thereby promoting bacterial vaginosis (BV) characterized by polymicrobial diversity. Additionally, Megasphaera co-occurs with Gardnerella vaginalis in polymicrobial biofilms adherent to the vaginal epithelium, enhancing community persistence and resistance to clearance mechanisms. These interactions underscore Megasphaera's role in stabilizing dysbiotic structures that shelter multiple anaerobes. Within the gut microbiome, Megasphaera strains, including novel isolates like NM10 and BL7, ferment undigested carbohydrates such as glucose into (SCFAs) like butyrate, , valerate, and caproate, supporting host energy harvest via colonic absorption. This metabolic activity complements the extensive glycobiome of symbiotic partners like Bacteroides thetaiotaomicron, where Megasphaera encodes diverse carbohydrate-active enzymes (CAZymes, e.g., GH43 family) that process intermediates from Bacteroides-degraded , fostering cross-feeding and niche partitioning in the environment. In the rumen microbiome of herbivores, Megasphaera elsdenii plays a critical role in lactate utilization, converting accumulated —produced by starch-fermenting bacteria during high-grain diets—into propionate and other volatile fatty acids, thereby mitigating subacute by stabilizing above 5.5. This process prevents lactate buildup that could otherwise lead to severe , with supplementation studies showing increased proportions of propionate and improved animal performance, such as enhanced average daily gain in . Regarding community dynamics, Megasphaera abundance often increases in response to dietary shifts that alter substrates and favor lactate-utilizing anaerobes over degraders, as observed in and models. Some strains engage in via autoinducer-2 (AI-2) signaling, coordinating interspecies interactions like formation with partners such as Streptococcus and Veillonella, which influences community assembly in dynamic environments.

Species

Type Species

Megasphaera elsdenii is the type species of the genus Megasphaera. It was originally isolated from the rumen of sheep by S.R. Elsden and formally described as Peptostreptococcus elsdenii by Gutiérrez et al. in 1959, based on strain LC1. In 1971, Rogosa transferred it to the newly established genus Megasphaera, recognizing its distinct characteristics such as its large coccal morphology and metabolic profile, which did not align with the Peptostreptococcus genus. The type strain is ATCC 25940 (equivalent to DSM 20460, JCM 1772, and CCUG 6199). This species consists of Gram-negative, nonmotile, obligately cocci measuring 2–2.5 μm in diameter, often occurring in pairs or short chains. It is capable of fermenting to propionate, along with production of valerate and caproate under specific conditions, contributing to its role in lactate utilization. Growth occurs optimally at 37°C in conditions on media supporting or glucose fermentation. The complete of the type ATCC 25940 is 2,478,842 in length, with a G+C content of 52.8 mol%, encoding 2,194 protein-coding genes. This genomic sequence serves as a key reference for understanding the phylogeny and metabolic capabilities of the Megasphaera . M. elsdenii is primarily distributed in the of ruminants such as sheep and , though it has also been detected in fecal samples as part of the .

Other Recognized Species

As of November 2025, the Megasphaera includes 16 validly published besides the M. elsdenii, reflecting its broad ecological distribution across human-associated microbiomes, animal s, and industrial environments like production. These demonstrate metabolic diversity, particularly in pathways. For example, M. paucivorans, validly published in 2006 and isolated from spoiled , exhibits limited substrate utilization, fermenting few carbohydrates and amino acid-related compounds under conditions. Similarly, M. cerevisiae, described in 1985 from spoiled , contributes to off-flavors through and glucose . In contrast, rumen-derived like M. hexanoica (2017) produce medium-chain carboxylic acids such as caproate from and alcohols, supporting chain elongation processes. M. butyrica (2022), also from rumen ecosystems, specializes in butyrate production from complex carbohydrates. Vaginal-associated species highlight further variation, often linked to anaerobic metabolism of amino acids and lactate. M. hutchinsoni (2021), M. lornae (2021), and M. vaginalis (2021), all isolated from the female genital tract, represent previously uncultured phylotypes (e.g., Megasphaera types 1 and 2) with distinct profiles in succinate and production; these differ from gut isolates in their limited fermentation but enhanced utilization. Human fecal species like M. indica (2010) focus on obligate fermentation of simple sugars with poor utilization of complex substrates. Identification of Megasphaera species relies on 16S rRNA gene similarity exceeding 98.7%, supplemented by whole-genome comparisons for closely related strains; numerous uncultured phylotypes are detected via metagenomic surveys in diverse microbiomes. Recent additions include M. coli (2025, bovine origin) and M. jansseni (2025), expanding the 's representation in animal and human colonic environments.

Significance

Human Health Associations

Megasphaera species are prominently associated with (BV), a common vaginal characterized by an overgrowth of bacteria. In particular, the phylotypes MP1 and MP2 exhibit overabundance in BV cases, with MP1 showing a stronger ( of 4.57 in non-pregnant women) compared to MP2 ( of 2.19). These phylotypes contribute to the shift from a Lactobacillus-dominated to a diverse community, exacerbating symptoms like and . The presence of Megasphaera in BV is linked to adverse reproductive outcomes, including and (PID). MP1 persists in the vaginal environment during pregnancy, detected in 75.4% of samples from pregnant women and transcriptionally active, potentially ascending to the upper genital tract and contributing to preterm premature (PPROM). BV, including overgrowth of Megasphaera species, is associated with heightened PID risk through facilitation of bacterial ascension to the upper genital tract, potentially leading to and tubal inflammation. In oral health, Megasphaera abundance is elevated in the of smokers, promoting that may contribute to periodontitis. alters the salivary microbiome, increasing Megasphaera genera alongside , which supports formation on dental surfaces and exacerbates gingival . This correlates with poorer periodontal outcomes in smokers compared to non-smokers. Regarding gut health, Megasphaera plays a : protective through short-chain (SCFA) production that mitigates , yet implicated in certain pathologies. Species like M. elsdenii ferment to valerate, an SCFA that supports gut barrier integrity and reduces inflammatory responses in conditions like . Conversely, M. micronuciformis has been isolated from human liver abscesses, suggesting opportunistic involvement in dysbiotic states leading to hepatic infections. In (IBS), Megasphaera alterations indicate , with reduced abundance in diarrhea-predominant IBS potentially disrupting microbial balance. Diagnostics for Megasphaera in human health contexts rely on molecular methods rather than routine culturing, which is challenging due to their strict anaerobiosis. The , based on Gram-stained vaginal smears, indirectly detects Megasphaera as small Gram-variable cocci contributing to high scores (7-10) indicative of BV. (PCR) assays targeting Megasphaera type 1 achieve high sensitivity (95.9%) and specificity (93.7%) for BV compared to Nugent scoring, often combined with markers like BVAB2. Targeted PCR for Megasphaera or related Clostridiales yields 99% sensitivity and 89% specificity, enabling precise detection in vaginal and potentially oral or gut samples.

Environmental and Animal Roles

In the rumen of herbivores such as and sheep, Megasphaera elsdenii plays a key role in by converting —produced during high-grain diets—into (SCFAs) including , propionate, butyrate, and valerate via the pathway. This process stabilizes ruminal by reducing accumulation, preventing subacute ruminal acidosis (SARA) and acute rumen acidosis (ARA), which can otherwise drop below 5.0 and impair balance. The SCFAs generated contribute to the host's energy supply, as rumen products overall provide 60-80% of a ruminant's maintenance energy requirements, with M. elsdenii enhancing efficiency during overload. Beyond the rumen, Megasphaera species support animal health in other herbivores. In the bovine gut, M. elsdenii supplementation acts as a probiotic to mitigate ruminal acidosis, improving feed efficiency and average daily gain in feedlot cattle. The bacterium has been detected in pig feces, where isolates like M. elsdenii J6 ferment lactate isomers, potentially aiding gut fermentation balance. Similarly, in horses, M. elsdenii attenuates lactate buildup in cecal cultures, increasing butyrate and valerate production to support hindgut health and reduce acidosis risk. In environmental applications, Megasphaera contributes to processes in . M. elsdenii oxidizes in up-flow blanket reactors, converting it to , propionate, and , which supports subsequent and yields comprising methane, , and CO2 at rates up to 25.1 L/L-reactor/day from lactate-rich organic waste. This degradation enhances removal (85-97%) in digesters processing municipal or . Ecologically, Megasphaera species occur in anoxic sediments, such as those in landfills or marine environments, where they participate in organic carbon degradation through fermentation, influencing carbon cycling by transforming carbohydrates and into SCFAs and gases. Additionally, M. elsdenii's capacity to catabolize from protein hydrolysates suggests potential for of amino acid-rich pollutants, such as those in industrial effluents or agricultural runoff, by deaminating substrates like those in to ammonia and organic acids.